Ubenimex Completed Phase 3 Trials for Chronic Obstructive Pulmonary Disease (COPD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01944176The Effects of Simvastatin on Th17 Cytokines and Th17 Polarizing Cytokine in COPD Patients